Treatment of diabetic ketoacidosis: should mode of insulin administration dictate use of intensive care facilities?

Am J Med. 2004 Sep 1;117(5):357-8. doi: 10.1016/j.amjmed.2004.06.020.
No abstract available

Publication types

  • Editorial
  • Review
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Diabetic Ketoacidosis / drug therapy*
  • Diabetic Ketoacidosis / economics
  • Drug Monitoring
  • Hospital Charges / statistics & numerical data
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / economics
  • Infusions, Intravenous
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Insulin / administration & dosage*
  • Insulin / economics
  • Intensive Care Units / economics
  • Intensive Care Units / statistics & numerical data*
  • Patient Selection
  • Safety
  • Treatment Outcome

Substances

  • Hypoglycemic Agents
  • Insulin